Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · ICU Medical (ICUI)

ICU Medical names Daniel Woolson as President, effective immediately

Neutral Impact 3 of 5 leadership Written later

ICU Medical's board appointed Daniel Woolson, 48, as President on September 30, 2024, effective immediately. Woolson has been Corporate Vice President and General Manager of Infusion Systems since 2017. The filing does not describe any financial impact or change to the company's outlook.

Key points

  • Board appointed Daniel Woolson, 48, as President on September 30, 2024, effective immediately
  • Woolson has served as Corporate Vice President, General Manager – Infusion Systems since 2017
  • Previously President, Respiratory Solutions at Becton Dickinson from March 2015 to November 2016

The filing

CompanyICU Medical (ICUI)
Form8-K, current report
Filed with the SECOct 2, 2024, 4:09 PM ET
Accession number0000883984-24-000032

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:01 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 02, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.